Promoting membrane technology through quantitative risk assessment for public health. Risk assessment of cryptosporidium in drinking water and membrane removal vs conventional treatment. Risk assessment of TTHMs removal from drinking water and number of cancer cases prevented per one million consumers.
This presentation is available to AMTA Members only.
- Kristina Mena, PhD
- University of Texas - Houston School of Public Health
- AMTA/SCMA Technology Transfer Workshop, El Paso, TX
- AMTA/SCMA Technology Transfer Workshop
- Public health risk assessment, Cryptosporidium removal, Trihalomethane reduction